Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Vocci

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
American Clinical Laboratory|June 1, 2002
The challenging interactions between antiretroviral agents and addiction drugsJag Khalsa, Sander Genser, Frank Vocci, et al.
Journal of Addiction Medicine|September 26, 2014
Clinical case conference: unobserved "home" induction onto buprenorphineJoshua D Lee, Jennifer McNeely, Ellie Grossman, et al.
Substance Abuse|December 2, 2008
Pharmacotherapy of methamphetamine addiction: an updateAhmed Elkashef, Frank Vocci, Glen Hanson, et al.
The American Journal of Drug and Alcohol Abuse|December 24, 2013
Dopamine D3 receptors as a therapeutic target for methamphetamine dependenceNeil E Paterson, Frank Vocci, Rajkumar J Sevak, et al.
Substance Abuse|December 2, 2008
Marijuana neurobiology and treatmentAhmed Elkashef, Frank Vocci, Marilyn Huestis, et al.
Contemporary Clinical Trials|June 5, 2007
Prevalence of abnormal liver-associated enzymes in cocaine experienced adults versus healthy volunteers during phase 1 clinical trialsLouis R Cantilena, Svetlana A Cherstniakova, George Saviolakis, et al.
Addiction (Abingdon, England)|March 19, 2005
Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependenceDeborah B Leiderman, Steve Shoptaw, Ann Montgomery, et al.
Journal of Addiction Medicine|October 2, 2024
Revisiting PreaddictionShannon C Miller, Sharon Levy, Andrew J Saxon, et al.
Psychopharmacology|June 29, 2022
Novel rapid-acting sublingual nicotine tablet as a cigarette substitution strategyJed E Rose, Frederique M Behm, Tanaia L Botts, et al.
Drug and Alcohol Dependence|November 22, 2007
The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study dayEugene Somoza, Peggy Somoza, Daniel Lewis, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
American Clinical Laboratory|June 1, 2002
The challenging interactions between antiretroviral agents and addiction drugsJag Khalsa, Sander Genser, Frank Vocci, et al.
Journal of Addiction Medicine|September 26, 2014
Clinical case conference: unobserved "home" induction onto buprenorphineJoshua D Lee, Jennifer McNeely, Ellie Grossman, et al.
Substance Abuse|December 2, 2008
Pharmacotherapy of methamphetamine addiction: an updateAhmed Elkashef, Frank Vocci, Glen Hanson, et al.
The American Journal of Drug and Alcohol Abuse|December 24, 2013
Dopamine D3 receptors as a therapeutic target for methamphetamine dependenceNeil E Paterson, Frank Vocci, Rajkumar J Sevak, et al.
Substance Abuse|December 2, 2008
Marijuana neurobiology and treatmentAhmed Elkashef, Frank Vocci, Marilyn Huestis, et al.
Contemporary Clinical Trials|June 5, 2007
Prevalence of abnormal liver-associated enzymes in cocaine experienced adults versus healthy volunteers during phase 1 clinical trialsLouis R Cantilena, Svetlana A Cherstniakova, George Saviolakis, et al.
Addiction (Abingdon, England)|March 19, 2005
Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependenceDeborah B Leiderman, Steve Shoptaw, Ann Montgomery, et al.
Journal of Addiction Medicine|October 2, 2024
Revisiting PreaddictionShannon C Miller, Sharon Levy, Andrew J Saxon, et al.
Psychopharmacology|June 29, 2022
Novel rapid-acting sublingual nicotine tablet as a cigarette substitution strategyJed E Rose, Frederique M Behm, Tanaia L Botts, et al.
Drug and Alcohol Dependence|November 22, 2007
The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study dayEugene Somoza, Peggy Somoza, Daniel Lewis, et al.
Pageof 4